Drug Topics

Think “hypoallergenic” pets are safe for all? Think again. Pharmacists debunk common asthma and allergy myths. Watch for expert tips to improve patient outcomes: hubs.li/Q04hDZKv0 #AsthmaCare #AllergyAwareness

Independent pharmacy faces challenges such as broken reimbursement, closures, and burnout, but Tom DePietro, PharmD, remains optimistic. Discover his insights on PBM reform and pharmacy adaptability: hubs.li/Q04hDWS00 #Pharmacy #Healthcare

Uniquely positioned to view the patient through a holistic lens, pharmacists routinely review comprehensive medication regimens across diabetes, cardiovascular, and renal therapies simultaneously. Learn More: hubs.li/Q04hCFpq0

Early weight loss with oral semaglutide predicts long-term success. “Early responders” saw up to 21.6% mean loss by week 64. Explore how to apply these insights in practice: hubs.li/Q04hCHSR0

Frontline pharmacists can drive health equity for women. Discover how to close clinical trial gaps and advance precision care in episode 13 of Scripted for Her. Watch Now: hubs.li/Q04hCJ0Y0 #HealthEquity #ClinicalResearch

Eli Lilly’s retatrutide shows an average 70.3-lb weight loss in TRIUMPH-1. Explore clinical insights, safety, and pharmacist roles in this breakthrough: hubs.li/Q04hDnr10 #obesity #clinicaltrials

The FDA’s new guidance on post-approval pregnancy safety studies sets a stronger standard for real-world drug safety. Discover key pharmacy insights and next steps: hubs.li/Q04hCKvC0 #pharmacy #FDA #maternalhealth

A rare Bundibugyo Ebola outbreak prompts a global health emergency. Pharmacists: review screening, triage, and infection control updates to aid containment. Read More: hubs.li/Q04hDkV40 #InfectionControl #Healthcare

One in 5 patients could benefit from routine PGx testing, yet community pharmacies face major barriers such as data silos, reimbursement gaps, and workforce knowledge. Explore the challenges: hubs.li/Q04htvj80 #pharmacy #PGx #healthcare

FDA leadership shakeup: CDER and CBER directors removed just days after Commissioner Makary’s exit. What does this mean for pharmacists and regulatory stability? Read More: hubs.li/Q04htr520 #FDA #Healthcare #Pharmacy

2026 marks a turning point for pharmacist–PBM relationships — and independent pharmacies stand to benefit most. For the first time, pharmacies have legal footing to challenge PBM practices without fear of reprisal. Read more here: hubs.li/Q04h5FnB0 #PBM #PharmacyNews

Nearly 600 generics added to TrumpRx, expanding access via partnerships with Mark Cuban Cost Plus Drugs, Amazon Pharmacy, and GoodRx—major price cuts on key therapies. Read More: hubs.li/Q04htyW10

Rare hantavirus outbreak tied to a cruise ship highlights urgent pharmacist roles. Early symptom recognition and safe triage are critical. Stay informed on best practices for patient care: hubs.li/Q04htsRg0 #pharmacy #publichealth

FDA approves golimumab-sldi (Immgolis, Immgolis Intri) as the first interchangeable biosimilars for Simponi/Simponi Aria, expanding access to affordable autoimmune care. Read More: hubs.li/Q04hh89P0 #biosimilars #FDA #rheumatoidarthritis #ulcerativecolitis

Discover how Black pharmacists have shaped health equity and social justice from 1865 to today. Pharmacists are being called to reclaim the legacy, because community care matters. Read More: hubs.li/Q04hh6B60 #HealthEquity #Pharmacy

Community pharmacies face a critical moment: PBM reforms promise change, but closures strain surviving locations. Tom DePietro, PharmD, shares key insights on navigating these shifts. Watch Now: hubs.li/Q04hhlrq0

FDA approves AstraZeneca’s baxdrostat, the first aldosterone synthase inhibitor for adults with uncontrolled hypertension, offering a new clinical option for resistant cases. Read More: hubs.li/Q04hh5lc0

AI awareness is high among pharmacists, but confidence and adoption lag due to gaps in training and infrastructure. Structured education is key to unlocking AI’s full potential in pharmacy. Read More: hubs.li/Q04h4Rvc0

Pharmacists are key to advancing women’s health, tackling disparities, expanding care, and supporting well-being at every age. Discover more from Scripted for Her: hubs.li/Q04h4Yfw0 #WomensHealth #Pharmacy

SCORPIO-PEP trial shows oral ensitrelvir reduces household COVID-19 risk by 67% as postexposure prophylaxis. Pharmacists play a key role in safe use. Read More: hubs.li/Q04h4WMH0